CAJ | 학술논문

近年来，随着内分泌治疗、化疗、靶向治疗和放疗研究的深入，有效改善了乳腺癌预后。三阴性乳腺癌作为一种特殊型乳腺癌，其分子生物学特性以及病例均比较独特，目前分子靶向治疗被广泛应用于该病的治疗中，该研究笔者就三阴性乳腺癌分子靶向治疗的研究进展进行研究和分析，望可为临床治疗方案的明确提供参考依据，以此进一步提高治疗效果。
근년래，수착내분비치료、화료、파향치료화방료연구적심입，유효개선료유선암예후。삼음성유선암작위일충특수형유선암，기분자생물학특성이급병례균비교독특，목전분자파향치료피엄범응용우해병적치료중，해연구필자취삼음성유선암분자파향치료적연구진전진행연구화분석，망가위림상치료방안적명학제공삼고의거，이차진일보제고치료효과。
In recent years, with the depth of endocrine therapy, chemotherapy, targeted therapy and radiotherapy research, to effectively improve the prognosis of breast cancer. Three negative breast cancer as a special type of breast cancer, the molecular biological characteristics and cases are relatively unique, at present, molecular targeted therapy has been widely used in the treatment of the disease, the author carried on research and analysis to the research progress of the three negative molecular targeted therapy, expected that can provided reference for the definition of clinical treatment , on this account to improve further the effects of treatment.